Although hematopoietic stem cells and progenitor cells (HPC) circulate, they only develop in hematopoietic stroma. This has led to the hypothesis that HPC must recognize and adhere to appropriate tissue of hematopoietic organs where specific cellular interactions can influence their growth. This application proposes to develop an assay that can be used to identify the cells and molecules that mediate these interactions. The methodology proposed is based on in vitro binding of target cells to tissue sections. This adhesion assay has been developed by others to identify lymphocyte surface molecules or """"""""homing"""""""" receptors responsible for organ-specific binding of lymphocytes. The possible relevance of this assay to HPC-stromal cell interactions has been suggested by preliminary studies showing differential binding patterns of bone marrow cells to sections of normal and genetically defective hematopoietic tissue. Physiologically relevant adhesion assays will be developed for normal HPC on sections of marrow and spleen obtained from normal donors and patients with hematological diseases. Initial studies will require the preparation of relatively pure populations of HPC. Current pilot studies using a combination of selection techniques have yielded cell populations with a 30% plating efficiency for CFU-GM, which satisfies this requirement. Once specific binding patterns for normal HPC have been defined, cell lines that mimic these specific binding patterns, as well as auto- logous variant cell lines that do not bind will be established. Paired autologous cell lines that are positive and negative (+/-) for binding will be used to generate monoclonal antibodies that can distinguish the +/- variants. These monoclonal antibodies will then be tested for their ability to block binding and/or distinguish distinct classes of HPC. The +/- variants will also be used to provide mRNA for differential cDNA hybridization techniques that can identify gene sequences expressed in one variant but not the other. Differentially expressed sequences will then be cloned. The proposed studies should provide a panel of antibodies and gene sequences that can be used as tools to define cellular interactions involved in normal hematopoietic regulation and identify mechanisms associated with disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034431-05
Application #
3232780
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-08-01
Project End
1993-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Iwata, M; Vieira, J; Byrne, M et al. (1999) Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1. Blood 94:572-8
Torok-Storb, B; Iwata, M; Graf, L et al. (1999) Dissecting the marrow microenvironment. Ann N Y Acad Sci 872:164-70
Roecklein, B A; Reems, J; Rowley, S et al. (1998) Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood. Biol Blood Marrow Transplant 4:61-8
Li, L; Milner, L A; Deng, Y et al. (1998) The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8:43-55
Boeckh, M; Hoy, C; Torok-Storb, B (1998) Occult cytomegalovirus infection of marrow stroma. Clin Infect Dis 26:209-10
Reems, J A; Mielcarek, M; Torok-Storb, B (1997) Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells. Biol Blood Marrow Transplant 3:133-41
Mielcarek, M; Reems, J; Torok-Storb, B (1997) Extrinsic control of stem cell fate: practical considerations. Stem Cells 15 Suppl 1:229-32; discussion 233-6
Mielcarek, M; Martin, P J; Torok-Storb, B (1997) Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89:1629-34
Kirk, J A; Radich, J; Edmands, S et al. (1996) Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am J Hematol 52:129-34
Mielcarek, M; Roecklein, B A; Torok-Storb, B (1996) CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87:574-80

Showing the most recent 10 out of 34 publications